{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:31:03Z","timestamp":1793089863336,"version":"4.5.0"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00929","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T07:39:46Z","timestamp":1579246786000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":138,"title":["New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine"],"prefix":"10.3389","volume":"10","author":[{"given":"Heng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Tesfaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11910-014-0473-5","article-title":"Diabetic neuropathy: mechanisms, emerging treatments, and subtypes","volume":"14","author":"Albers","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11883-017-0680-z","article-title":"The diabetic foot as a proxy for cardiovascular events and mortality review","volume":"19","author":"Dietrich","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1007\/s00125-018-4723-y","article-title":"Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study","volume":"61","author":"Vadiveloo","year":"2018","journal-title":"Diabetologia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.diabres.2015.04.031","article-title":"Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: a review of the literature","volume":"109","author":"Alleman","year":"2015","journal-title":"Diab Res Clin Practice"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.diabres.2018.08.020","article-title":"A new look at painful diabetic neuropathy","volume":"144","author":"Sloan","year":"2018","journal-title":"Diab Res Clin Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jdiacomp.2014.10.013","article-title":"Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy","volume":"29","author":"Sadosky","year":"2015","journal-title":"J Diabetes Complications"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1093\/pm\/pnz071","article-title":"Psychosocial factors in painful diabetic neuropathy: a systematic review of treatment trials and survey studies","volume":"20","author":"Kioskli","year":"2019","journal-title":"Pain Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the american diabetes association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.2337\/dc12-1964","article-title":"Mechanisms and management of diabetic painful distal symmetrical polyneuropathy","volume":"36","author":"Tesfaye","year":"2013","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11892-019-1150-5","article-title":"Painful and painless diabetic neuropathies: what is the difference?","volume":"19","author":"Shillo","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1097\/j.pain.0000000000001301","article-title":"Using stratified medicine to understand, diagnose, and treat neuropathic pain","volume":"159","author":"Themistocleous","year":"2018","journal-title":"Pain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.2337\/diab.46.2.S54","article-title":"Classification, differential diagnosis, and staging of diabetic peripheral neuropathy","volume":"46","author":"Thomas","year":"1997","journal-title":"Diabetes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1097\/j.pain.0000000000000465","article-title":"Diabetic peripheral neuropathy may not be as its name suggests: evidence from magnetic resonance imaging","volume":"157","author":"Tesfaye","year":"2016","journal-title":"Pain"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/WNL.47.4.1042","article-title":"Quantitation of epidermal nerves in diabetic neuropathy","volume":"47","author":"Kennedy","year":"1996","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/00005072-199612000-00001","article-title":"Pathologic alterations in the diabetic neuropathies of humans: a review","volume":"55","author":"Dyck","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF01257917","article-title":"Pathological changes in the central and peripheral nervous system of young long-term diabetics: I. Diabetic encephalopathy","volume":"1","author":"Reske-Nielsen","year":"1966","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/BF01241031","article-title":"Pathological changes in the central and peripheral nervous system of young long-term diabetics. II. The spinal cord and peripheral nerves","volume":"4","author":"Reske-Nielsen","year":"1968","journal-title":"Diabetologia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.2337\/dc06-0650","article-title":"Early involvement of the spinal cord in diabetic peripheral neuropathy","volume":"29","author":"Selvarajah","year":"2006","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2337\/dc13-2610","article-title":"Magnetic resonance neuroimaging study of brain structural differences in diabetic peripheral neuropathy","volume":"37","author":"Selvarajah","year":"2014","journal-title":"Diabetes Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s001250100001","article-title":"Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy","volume":"44","author":"Cameron","year":"2001","journal-title":"Diabetologia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-444-53480-4.00001-1","article-title":"Epidemiology of polyneuropathy in diabetes and prediabetes","volume":"126","author":"Ziegler","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/acn3.531","article-title":"Diabetes and obesity are the main metabolic drivers of peripheral neuropathy","volume":"5","author":"Callaghan","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2337\/dc17-2062","article-title":"Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-denmark","volume":"41","author":"Andersen","year":"2018","journal-title":"Diabetes Care"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.2337\/dc11-1108","article-title":"Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K","volume":"34","author":"Abbott","year":"2011","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1097\/j.pain.0000000000001378","article-title":"A cross-sectional study investigating frequency and features of definitely diagnosed diabetic painful polyneuropathy","volume":"159","author":"Truini","year":"2018","journal-title":"Pain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1526-4637.2008.00555.x","article-title":"Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA\/KORA Augsburg Surveys S2 and S3","volume":"10","author":"Ziegler","year":"2009","journal-title":"Pain Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0168-8227(99)00112-6","article-title":"Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life","volume":"47","author":"Galer","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/j.pain.0000000000000491","article-title":"The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy","volume":"157","author":"Themistocleous","year":"2016","journal-title":"Pain"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1097\/j.pain.0000000000001034","article-title":"Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study","volume":"158","author":"Raputova","year":"2017","journal-title":"Pain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.2337\/diacare.25.11.2048","article-title":"Validation of the toronto clinical scoring system for diabetic polyneuropathy","volume":"25","author":"Bril","year":"2002","journal-title":"Diabetes Care"},{"key":"B36","doi-asserted-by":"publisher","first-page":"903\u201312;","DOI":"10.1111\/j.1468-1331.2010.03023.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society","volume":"17","author":"Lauria","year":"2010","journal-title":"Eur J Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/mus.20889","article-title":"Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies","volume":"37","author":"Vlckova-Moravcova","year":"2008","journal-title":"Muscle Nerve"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.2337\/db07-0285","article-title":"Surrogate markers of small fiber damage in human diabetic neuropathy","volume":"56","author":"Quattrini","year":"2007","journal-title":"Diabetes"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.2337\/diacare.27.8.1974","article-title":"Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients","volume":"27","author":"Pittenger","year":"2004","journal-title":"Diabetes Care"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/brain\/awh180","article-title":"Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments","volume":"127","author":"Shun","year":"2004","journal-title":"Brain"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1093\/brain\/awn093","article-title":"The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology","volume":"131","author":"Devigili","year":"2008","journal-title":"Brain"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00415-009-5065-y","article-title":"The value of skin biopsy with recording of intraepidermal nerve fiber density and quantitative sensory testing in the assessment of small fiber involvement in patients with different causes of polyneuropathy","volume":"256","author":"Nebuchennykh","year":"2009","journal-title":"J Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0180175","DOI":"10.1371\/journal.pone.0180175","article-title":"Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy","volume":"12","author":"Alam","year":"2017","journal-title":"PLoS ONE"},{"key":"B44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/mus.20732","article-title":"Intraepidermal nerve fiber density as a marker of early diabetic neuropathy","volume":"35","author":"Umapathi","year":"2007","journal-title":"Muscle Nerve"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00125-017-4438-5","article-title":"Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy","volume":"60","author":"Bonhof","year":"2017","journal-title":"Diabetologia"},{"key":"B46","first-page":"31","article-title":"Nerve and vascular biomarkers in skin biopsies differentiate painful from painless advanced diabetic peripheral neuropathy","volume":"2017","author":"Shillo","year":"2017","journal-title":"EASD"},{"key":"B47","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jpain.2013.03.005","article-title":"Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy","volume":"14","author":"Cheng","year":"2013","journal-title":"J Pain"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.2337\/dc06-0224","article-title":"Lifestyle intervention for pre-diabetic neuropathy","volume":"29","author":"Smith","year":"2006","journal-title":"Diabetes Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jpain.2017.02.429","article-title":"The potential role of sensory testing, skin biopsy, and functional brain imaging as biomarkers in chronic pain clinical trials: IMMPACT considerations","volume":"18","author":"Smith","year":"2017","journal-title":"J Pain"},{"key":"B50","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.clinthera.2018.04.001","article-title":"Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy","volume":"40","author":"Iqbal","year":"2018","journal-title":"Clin Ther"},{"key":"B51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1109\/IEMBS.2007.4352351","article-title":"An approach to the assessment of diabetic neuropathy based on dynamic pupillometry","volume":"2007","author":"Ferrari","year":"2007","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"B52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1475-925X-9-26","article-title":"Using dynamic pupillometry as a simple screening tool to detect autonomic neuropathy in patients with diabetes: a pilot study","volume":"9","author":"Ferrari","year":"2010","journal-title":"Biomed Eng Online"},{"key":"B53","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00125-003-1086-8","article-title":"Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients","volume":"46","author":"Malik","year":"2003","journal-title":"Diabetologia"},{"key":"B54","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2337\/dc11-1396","article-title":"Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity study","volume":"35","author":"Ahmed","year":"2012","journal-title":"Diabetes Care"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.2337\/dc10-0253","article-title":"Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy","volume":"33","author":"Tavakoli","year":"2010","journal-title":"Diabetes Care"},{"key":"B56","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/mus.24553","article-title":"Corneal confocal microscopy for the diagnosis of diabetic autonomic neuropathy","volume":"52","author":"Tavakoli","year":"2015","journal-title":"Muscle Nerve"},{"key":"B57","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2337\/dc14-2114","article-title":"Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes","volume":"38","author":"Pritchard","year":"2015","journal-title":"Diabetes Care"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jdiacomp.2016.07.004","article-title":"A rapid decline in corneal small fibers and occurrence of foot ulceration and Charcot foot","volume":"30","author":"Dehghani","year":"2016","journal-title":"J Diabetes Complications"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1167\/iovs.08-3143","article-title":"Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy","volume":"50","author":"van Dijk","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.2337\/dc15-2675","article-title":"Retinal nerve fiber layer loss in patients with type 2 diabetes and diabetic neuropathy","volume":"39","author":"Park","year":"2016","journal-title":"Diabetes Care"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1177\/44.12.8985139","article-title":"Basement membrane abnormalities in human eyes with diabetic retinopathy","volume":"44","author":"Ljubimov","year":"1996","journal-title":"J Histochem Cytochem"},{"key":"B63","doi-asserted-by":"publisher","first-page":"Bio234","DOI":"10.1167\/iovs.17-21801","article-title":"Presence of peripheral neuropathy is associated with progressive thinning of retinal nerve fiber layer in type 1 diabetes","volume":"58","author":"Dehghani","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"449","DOI":"10.15386\/cjmed-491","article-title":"Measurement of current perception thresholds using the Neurometer((R)) - applicability in diabetic neuropathy","volume":"88","author":"Inceu","year":"2015","journal-title":"Clujul Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/147323000503300410","article-title":"Assessment of peripheral neuropathy using measurement of the current perception threshold with the neurometer in patients with type 2 diabetes mellitus","volume":"33","author":"Matsutomo","year":"2005","journal-title":"J Int Med Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s004150050370","article-title":"Quantitative sensory testing and risk factors of diabetic sensory neuropathy","volume":"246","author":"Cheng","year":"1999","journal-title":"J Neurol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1046\/j.1464-5491.2002.00759.x","article-title":"Comparison of vibration perception thresholds obtained with the Neurothesiometer and the CASE IV and relationship to nerve conduction studies","volume":"19","author":"Bril","year":"2002","journal-title":"Diabetic Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jdiacomp.2006.10.007","article-title":"Assessment of sensory neuropathy in diabetic patients without diabetic foot problems","volume":"22","author":"Nather","year":"2008","journal-title":"J Diabetes Complications"},{"key":"B69","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4093\/dmj.2018.0068","article-title":"Patterns of nerve conduction abnormalities in patients with type 2 diabetes mellitus according to the clinical phenotype determined by the current perception threshold","volume":"42","author":"Park","year":"2018","journal-title":"Diabetes Metab J"},{"key":"B70","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4093\/dmj.2014.38.4.285","article-title":"Assessment of diabetic polyneuropathy and autonomic neuropathy using current perception threshold in korean patients with diabetes mellitus","volume":"38","author":"Koo","year":"2014","journal-title":"Diabetes Metab J"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e86515","DOI":"10.1371\/journal.pone.0086515","article-title":"Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS ONE"},{"key":"B72","doi-asserted-by":"publisher","first-page":"390","DOI":"10.5114\/aoms.2016.59265","article-title":"Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus","volume":"12","author":"Chatzikosma","year":"2016","journal-title":"Arch Med Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1932296814551044","article-title":"Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring","volume":"9","author":"Sharma","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/dme.13630","article-title":"One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot","volume":"35","author":"Binns-Hall","year":"2018","journal-title":"Diabetic Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1464-5491.2009.02677.x","article-title":"Sudomotor dysfunction is associated with foot ulceration in diabetes","volume":"26","author":"Tentolouris","year":"2009","journal-title":"Diabetic Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jdiacomp.2009.09.006","article-title":"New diagnostic tests for diabetic distal symmetric polyneuropathy","volume":"25","author":"Papanas","year":"2011","journal-title":"J Diabetes Complications"},{"key":"B77","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-2005-837735","article-title":"Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients","volume":"113","author":"Papanas","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1464-5491.2007.02280.x","article-title":"Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus","volume":"24","author":"Liatis","year":"2007","journal-title":"Diabetic Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1055\/s-2007-984455","article-title":"A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes","volume":"116","author":"Papanas","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s00125-008-0987-y","article-title":"The Neuropad test: a visual indicator test for human diabetic neuropathy","volume":"51","author":"Quattrini","year":"2008","journal-title":"Diabetologia"},{"key":"B81","doi-asserted-by":"publisher","first-page":"847854","DOI":"10.1155\/2015\/847854","article-title":"Automated quantification of neuropad improves its diagnostic ability in patients with diabetic neuropathy","volume":"2015","author":"Ponirakis","year":"2015","journal-title":"J Diabetes Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1089\/dia.2013.0129","article-title":"Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction","volume":"15","author":"Casellini","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"B83","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3389\/fneur.2018.00803","article-title":"Sudomotor testing of diabetes polyneuropathy","volume":"9","author":"Krieger","year":"2018","journal-title":"Front Neurol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0138224","DOI":"10.1371\/journal.pone.0138224","article-title":"SUDOSCAN: a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy","volume":"10","author":"Selvarajah","year":"2015","journal-title":"PLoS ONE"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e0183973","DOI":"10.1371\/journal.pone.0183973","article-title":"Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy","volume":"12","author":"Goel","year":"2017","journal-title":"PLoS ONE"},{"key":"B86","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jdiacomp.2014.02.013","article-title":"The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy","volume":"28","author":"Smith","year":"2014","journal-title":"J Diabetes Complications"},{"key":"B87","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10286-018-0540-0","article-title":"Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function?","volume":"29","author":"Rajan","year":"2019","journal-title":"Clin Auton Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007543.pub2","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B89","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s11892-014-0528-7","article-title":"Glucose control and diabetic neuropathy: lessons from recent large clinical trials","volume":"14","author":"Ang","year":"2014","journal-title":"Curr Diabetes Rep"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2337\/dc11-0903","article-title":"Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study","volume":"34","author":"Charles","year":"2011","journal-title":"Diabetes Care"},{"key":"B91","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"Intensive","year":"1998","journal-title":"Lancet"},{"key":"B92","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2337\/dc09-1471","article-title":"Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"33","author":"Calles-Escandon","year":"2010","journal-title":"Diabetes Care"},{"key":"B93","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"B94","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.2337\/dc13-0012","article-title":"Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort","volume":"36","author":"Pop-Busui","year":"2013","journal-title":"Diabetes Care"},{"key":"B96","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S2213-8587(14)70067-1","article-title":"Why are there no good treatments for diabetic neuropathy?","volume":"2","author":"Malik","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1177\/0300060518756540","article-title":"Effect of alpha-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy","volume":"46","author":"Agathos","year":"2018","journal-title":"J Int Med Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/j.1464-5491.2012.03684.x","article-title":"Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy","volume":"29","author":"Hotta","year":"2012","journal-title":"Diabetic Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/B978-0-444-53480-4.00022-9","article-title":"Therapy for diabetic neuropathy: an overview","volume":"126","author":"Calabek","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/dmrr.2397","article-title":"Whither pathogenetic treatments for diabetic polyneuropathy?","volume":"29","author":"Boulton","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"B101","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1210\/er.2018-00107","article-title":"Emerging biomarkers, tools, and treatments for diabetic polyneuropathy","volume":"40","author":"Bonhof","year":"2019","journal-title":"Endocr Rev"},{"key":"B102","volume-title":"National Institute for Health and Care Excellence: Clinical Guidelines Neuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-specialist Settings.","year":"2013"},{"key":"B103","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/dmrr.1225","article-title":"Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management","volume":"27","author":"Tesfaye","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2147\/JPR.S145999","article-title":"Mirogabalin and emerging therapies for diabetic neuropathy","volume":"11","author":"Javed","year":"2018","journal-title":"J Pain Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"B106","doi-asserted-by":"publisher","first-page":"Cd007938","DOI":"10.1002\/14651858.CD007938.pub4","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B107","first-page":"E705","article-title":"Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis","volume":"16","author":"Rudroju","year":"2013","journal-title":"Pain Physician"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.2337\/dc07-2105","article-title":"Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses","volume":"31","author":"Freeman","year":"2008","journal-title":"Diabetes Care"},{"key":"B109","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jdiacomp.2016.03.019","article-title":"Glycemic and serum lipid control in patients with painful diabetic peripheral neuropathy treated with pregabalin","volume":"31","author":"Parsons","year":"2017","journal-title":"J Diabetes Complications"},{"key":"B110","year":"2018","journal-title":"Deaths Related To Drug Poisoning in England and Wales Statistical Bulletins."},{"key":"B111","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13300-018-0550-x","article-title":"Pregabalin in the management of painful diabetic neuropathy: a narrative review","volume":"10","author":"Azmi","year":"2019","journal-title":"Diabetes Ther"},{"key":"B112","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40263-014-0164-4","article-title":"Misuse and abuse of pregabalin and gabapentin: cause for concern?","volume":"28","author":"Schifano","year":"2014","journal-title":"CNS Drugs"},{"key":"B113","doi-asserted-by":"publisher","first-page":"Cd007115","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","volume":"2014","author":"Lunn","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.pain.2013.05.043","article-title":"Duloxetine and pregabalin: high-dose monotherapy or their combination? The \u201cCOMBO-DN study\u201d\u2013a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain","volume":"154","author":"Tesfaye","year":"2013","journal-title":"Pain"},{"key":"B115","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/2040622314552071","article-title":"Treatment of painful diabetic neuropathy","volume":"6","author":"Javed","year":"2015","journal-title":"Therap Adv Chronic Dis"},{"key":"B116","doi-asserted-by":"publisher","first-page":"Cd008242","DOI":"10.1002\/14651858.CD008242.pub3","article-title":"Amitriptyline for neuropathic pain in adults","volume":"2015","author":"Moore","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B117","doi-asserted-by":"publisher","first-page":"639","DOI":"10.7326\/M14-0511","article-title":"Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis","volume":"161","author":"Griebeler","year":"2014","journal-title":"Ann Intern Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jdiacomp.2005.05.007","article-title":"Treatment of intractable painful diabetic neuropathy with intravenous lignocaine","volume":"20","author":"Viola","year":"2006","journal-title":"J Diabetes Complications"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e000148","DOI":"10.1136\/bmjdrc-2015-000148","article-title":"Vitamin D for the treatment of painful diabetic neuropathy","volume":"4","author":"Basit","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B120","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.dsx.2018.12.014","article-title":"Dose vitamin D supplementations improve peripheral diabetic neuropathy? A before-after clinical trial","volume":"13","author":"Ghadiri-Anari","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1177\/193229681300700510","article-title":"Electrical stimulation as an adjunctive treatment of painful and sensory diabetic neuropathy","volume":"7","author":"Thakral","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"e73764","DOI":"10.1371\/journal.pone.0073764","article-title":"Manual acupuncture for treatment of diabetic peripheral neuropathy: a systematic review of randomized controlled trials","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS ONE"},{"key":"B123","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype to reveal neural mechanisms","volume":"73","author":"von Hehn","year":"2012","journal-title":"Neuron"},{"key":"B124","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/j.pain.0000000000001088","article-title":"Individualized neuropathic pain therapy based on phenotyping: are we there yet?","volume":"159","author":"Forstenpointner","year":"2018","journal-title":"Pain"},{"key":"B125","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values","volume":"123","author":"Rolke","year":"2006","journal-title":"Pain"},{"key":"B126","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/j.pain.0000000000000753","article-title":"Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles","volume":"158","author":"Baron","year":"2017","journal-title":"Pain"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.pain.2014.08.014","article-title":"The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study","volume":"155","author":"Demant","year":"2014","journal-title":"Pain"},{"key":"B128","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.pain.2014.08.020","article-title":"Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study","volume":"155","author":"Bouhassira","year":"2014","journal-title":"Pain"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.pain.2012.02.021","article-title":"Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy","volume":"153","author":"Yarnitsky","year":"2012","journal-title":"Pain"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1007\/s00125-008-1139-0","article-title":"Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus","volume":"51","author":"Selvarajah","year":"2008","journal-title":"Diabetologia"},{"key":"B131","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.acra.2012.02.004","article-title":"Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy","volume":"19","author":"Petrou","year":"2012","journal-title":"Acad Radiol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2337\/dc10-1550","article-title":"Microvascular perfusion abnormalities of the Thalamus in painful but not painless diabetic polyneuropathy: a clue to the pathogenesis of pain in type 1 diabetes","volume":"34","author":"Selvarajah","year":"2011","journal-title":"Diabetes Care"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2337\/db16-1181","article-title":"Spinal disinhibition in experimental and clinical painful diabetic neuropathy","volume":"66","author":"Marshall","year":"2017","journal-title":"Diabetes"},{"key":"B134","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1471-2202-10-138","article-title":"Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in diabetic neuropathic pain","volume":"10","author":"Cauda","year":"2009","journal-title":"BMC Neurosci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2337\/db18-0509","article-title":"Structural and functional abnormalities of the primary somatosensory cortex in diabetic peripheral neuropathy: a multimodal MRI study","volume":"68","author":"Selvarajah","year":"2019","journal-title":"Diabetes"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/ALN.0000000000000017","article-title":"Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients","volume":"119","author":"Harris","year":"2013","journal-title":"Anesthesiology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1136\/jnnp-2017-316601","article-title":"Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain","volume":"89","author":"Watanabe","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s13300-018-0460-y","article-title":"Cerebral biochemical effect of pregabalin in patients with painful diabetic neuropathy: a randomized controlled trial","volume":"9","author":"De Jaeger","year":"2018","journal-title":"Diabetes Ther"},{"key":"B139","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/j.pain.0000000000001164","article-title":"Systematic review and meta-analysis of genetic risk factors for neuropathic pain","volume":"159","author":"Veluchamy","year":"2018","journal-title":"Pain"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ebiom.2015.08.001","article-title":"A genome-wide association study provides evidence of sex-specific involvement of Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46) with diabetic neuropathic pain","volume":"2","author":"Meng","year":"2015","journal-title":"EBioMedicine"},{"key":"B141","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ejp.560","article-title":"A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain","volume":"19","author":"Meng","year":"2015","journal-title":"Eur J Pain"},{"key":"B142","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/AJP.0000000000000205","article-title":"SCN9A variants may be implicated in neuropathic pain associated with diabetic peripheral neuropathy and pain severity","volume":"31","author":"Li","year":"2015","journal-title":"Clin J Pain"},{"key":"B143","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ana.22485","article-title":"Gain of function Nanu1.7 mutations in idiopathic small fiber neuropathy","volume":"71","author":"Faber","year":"2012","journal-title":"Ann Neurol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1744806919849802","DOI":"10.1177\/1744806919849802","article-title":"A gain-of-function sodium channel beta2-subunit mutation in painful diabetic neuropathy","volume":"15","author":"Alsaloum","year":"2019","journal-title":"Mol Pain"},{"key":"B145","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/j.pain.0000000000001116","article-title":"Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy","volume":"159","author":"Blesneac","year":"2018","journal-title":"Pain"},{"key":"B146","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/brain\/awy329","article-title":"Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial","volume":"142","author":"de Greef","year":"2019","journal-title":"Brain"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00929\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T07:40:04Z","timestamp":1579246804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00929\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":146,"alternative-id":["10.3389\/fendo.2019.00929"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00929","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"article-number":"929"}}